Breast cancer chemo study tracks calcium and vitamin changes
NCT ID NCT03249389
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how calcium and vitamin markers change in 146 breast cancer patients receiving standard adjuvant chemotherapy. Researchers measured these markers before, during, and after treatment to understand metabolic effects. The goal was to see how often patients develop high calcium in urine and how vitamin balance shifts over the course of chemotherapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better manage calcium and vitamin levels in breast cancer patients undergoing chemotherapy.
- What could go wrong
- This is an observational study with no treatment being tested, so it won't directly improve outcomes. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut régional du Cancer de Montpellier
Montpellier, 34298, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?